EPISODE · Mar 8, 2021 · 7 MIN
Mid-Brain Organoids
from New Matter: Inside the Minds of SLAS Scientists · host SLAS
Jens Schwamborn and his company OrganoTherapeutics is using their technology (human-specific mini-brains) to treat Parkinson's. He walks Marshall through how they grew their young company through the time of a global pandemic and the opportunities they made from it to use their technology to support research in therapies related to SARS COV 2. OrganoTherapuetics is a SLAS2021 New Product Award winner and an participated in Innovation AveNEW at SLAS2021 Digital. Upcoming Events:SLAS Meet-UpsLeiden, Netherlands (10 September 2026)Tübingen, Germany (20 October 2026)SLAS 2026 Sample Management Symposium (October 21-22, 2026 | South San Francisco, California)SLAS2027 International Conference & Exhibition (January 30 - February 3, 2027 | San Diego, California)View the full events calendar
Embed this episode
What this episode covers
Jens Schwamborn and his company OrganoTherapeutics is using their technology (human-specific mini-brains) to treat Parkinson's. He walks Marshall through how they grew their young company through the time of a global pandemic and the opportunities they made from it to use their technology to support research in therapies related to SARS COV 2. OrganoTherapuetics is a SLAS2021 New Product Award winner and an participated in Innovation AveNEW at SLAS2021 Digital. ...
NOW PLAYING
Mid-Brain Organoids
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.